| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Accounting Officer | Chief Accounting Officer
1 company
Malabre Richard C serves as a SVP, Chief Accounting Officer at AKBA. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $416K at current prices.
Historically, Malabre Richard C's trades have earned a middling insider score of 69/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +60.9%.
The biggest single holding is AKBA (~$416K) as SVP, Chief Accounting Officer. The recent filings there lean toward selling, a net 108,060 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 49,524 | $1.39 | $68,838.36 | -14.2% | +8.7% | - | |
| Jun 9, 2025 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Accounting Officer | Sale+OE10b5-1 | 15,000 | $4.01 | $60,150.00 | -5.3% | -18.3% | -76.0% | |
| Jun 4, 2025 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 13,334 | $3.53 | $47,069.02 | -4.8% | -14.6% | -73.4% | |
| Feb 3, 2025 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 30,202 | $2.10 | $63,424.20 | -9.7% | +10.4% | -33.5% |